ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      USA

      iShares Evolved U.S. Innovative Healthcare ETF

      The iShares Evolved U.S. Innovative Healthcare ETF (the ¡°Fund¡±) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system.

      $34.13

      Compare similar ETFs

      Fund Size
      Dividend
      Fees
      Current
      Evolved U.S. Innovative Healthcare ETF IEIH
      Fund Size
      $36.9M
      Dividend
      -
      Fees
      -
      Core S&P 500 ETF IVV
      Fund Size
      $626B
      Dividend
      1.2%
      Fees
      0.03%
      Core U.S. Aggregate Bond ETF AGG
      Fund Size
      $128B
      Dividend
      3.8%
      Fees
      0.03%
      S&P 500 Equal Weight ETF RSP
      Fund Size
      $73B
      Dividend
      1.5%
      Fees
      -
      Schwab U.S. Dividend Equity ETF SCHD
      Fund Size
      $68.2B
      Dividend
      3.7%
      Fees
      0.06%
      View 400 similar ETFs →

      Average metrics of all companies in portfolio

      Compare to
      Market
      Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $184B
      Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 1.54 %
      Beta Indicates the relationship between the price performance of a share and the market. 0.6194
      P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 32.46
      Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -39.21
      Profitable Companies 72
      PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 82.69
      Price to Sales Ratio Market cap divided by the revenue in the most recent year. 6.62
      Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 17.3
      Compare to
      Market
      Enterprise Value to EBIT Enterprise Value divided by EBIT 19.41
      Enterprise Value to Revenue Enterprise value divided by revenue 56.59
      Total Debt to Enterprise Value Total debt divided by enterprise value 0.07
      Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. NaN
      Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -11122.18%
      Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
      Return on Equity Equity divided by market cap. 11.98%
      Return on Assets Indicates a company's profitability in relation to its total assets. 4.72%
      Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -34.49%

      Industries

      Healthcare 87.4%
      Industrials 0.7%
      Consumer Staples 0.4%
      Finance 0.4%
      Consumer Discretionary 0.4%
      Other 0.4%
      Technology 0.4%
      N/A 10.0%

      Market cap

      Micro Cap 2%
      Small Cap 5%
      Mid Cap 8%
      Large Cap 50%
      Mega Cap 34%

      269 Investments

      P/E-Ratio
      Total Investment
      Weight
      Johnson & Johnson logo

      JNJ - Manufacturing

      Johnson & Johnson

      P/E-Ratio
      18.9
      Total Investment
      $3.77M
      Weight
      10.2%
      BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES logo

      BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES

      P/E-Ratio
      n/a
      Total Investment
      $2.84M
      Weight
      7.7%
      Eli Lilly & Co logo

      LLY - Manufacturing

      Eli Lilly & Co

      P/E-Ratio
      47.7
      Total Investment
      $2.78M
      Weight
      7.5%
      AbbVie Inc logo

      ABBV - Manufacturing

      AbbVie Inc

      P/E-Ratio
      98.9
      Total Investment
      $2.24M
      Weight
      6.1%
      Merck & Co Inc logo

      MRK - Manufacturing

      Merck & Co Inc

      P/E-Ratio
      12.9
      Total Investment
      $2.12M
      Weight
      5.8%
      Bristol-Myers Squibb Co logo

      BMY - Manufacturing

      Bristol-Myers Squibb Co

      P/E-Ratio
      -16.7
      Total Investment
      $1.97M
      Weight
      5.4%
      Vertex Pharmaceuticals Inc logo

      VRTX - Manufacturing

      Vertex Pharmaceuticals Inc

      P/E-Ratio
      27.6
      Total Investment
      $1.89M
      Weight
      5.1%
      Moderna Inc logo

      MRNA - Manufacturing

      Moderna Inc

      P/E-Ratio
      -3.2
      Total Investment
      $1.66M
      Weight
      4.5%
      Amgen Inc logo

      AMGN - Manufacturing

      Amgen Inc

      P/E-Ratio
      23.4
      Total Investment
      $1.61M
      Weight
      4.4%
      Gilead Sciences Inc logo

      GILD - Manufacturing

      Gilead Sciences Inc

      P/E-Ratio
      22.3
      Total Investment
      $1.48M
      Weight
      4.0%
      Regeneron Pharmaceuticals Inc logo

      REGN - Manufacturing

      Regeneron Pharmaceuticals Inc

      P/E-Ratio
      13.7
      Total Investment
      $1.46M
      Weight
      4.0%
      Zoetis Inc logo

      ZTS - Manufacturing

      Zoetis Inc

      P/E-Ratio
      26.7
      Total Investment
      $913k
      Weight
      2.5%
      Biogen Inc logo

      BIIB - Manufacturing

      Biogen Inc

      P/E-Ratio
      12.6
      Total Investment
      $843k
      Weight
      2.3%
      Seagen Inc logo

      SGEN - Manufacturing

      Seagen Inc

      P/E-Ratio
      -69.2
      Total Investment
      $672k
      Weight
      1.8%
      Alnylam Pharmaceuticals Inc logo

      ALNY - Manufacturing

      Alnylam Pharmaceuticals Inc

      P/E-Ratio
      -181.5
      Total Investment
      $542k
      Weight
      1.5%
      Horizon Therapeutics Plc logo

      HZNP - Manufacturing

      Horizon Therapeutics Plc

      P/E-Ratio
      51.1
      Total Investment
      $478k
      Weight
      1.3%
      BioMarin Pharmaceutical Inc logo

      BMRN - Manufacturing

      BioMarin Pharmaceutical Inc

      P/E-Ratio
      17.0
      Total Investment
      $463k
      Weight
      1.3%
      Incyte Corp logo

      INCY - Professional, Scientific, and Technical Services

      Incyte Corp

      P/E-Ratio
      18.8
      Total Investment
      $400k
      Weight
      1.1%
      Royalty Pharma PLC logo

      RPRX - Manufacturing

      Royalty Pharma PLC

      P/E-Ratio
      14.9
      Total Investment
      $284k
      Weight
      0.8%
      AstraZeneca PLC logo

      AZN - Health Technology

      AstraZeneca PLC

      P/E-Ratio
      29.2
      Total Investment
      $257k
      Weight
      0.7%
      United Therapeutics Corp logo

      UTHR - Manufacturing

      United Therapeutics Corp

      P/E-Ratio
      11.1
      Total Investment
      $239k
      Weight
      0.6%
      Neurocrine Biosciences Inc logo

      NBIX - Manufacturing

      Neurocrine Biosciences Inc

      P/E-Ratio
      39.7
      Total Investment
      $236k
      Weight
      0.6%
      Jazz Pharmaceuticals PLC logo

      Jazz Pharmaceuticals PLC

      P/E-Ratio
      n/a
      Total Investment
      $231k
      Weight
      0.6%
      Biohaven Pharmaceutical Holding Co Ltd logo

      Biohaven Pharmaceutical Holding Co Ltd

      P/E-Ratio
      n/a
      Total Investment
      $231k
      Weight
      0.6%
      IQVIA Holdings Inc logo

      IQV - Health Care and Social Assistance

      IQVIA Holdings Inc

      P/E-Ratio
      26.5
      Total Investment
      $218k
      Weight
      0.6%
      HoMEÔçÒÒŮѸÀ×